{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By STEVEN DAVIDOFF SOLOMON", "person": [{"middlename": "Davidoff", "firstname": "Steven", "lastname": "SOLOMON", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": null, "type_of_material": "News", "word_count": "959", "lead_paragraph": "Mylan and Perrigo reincorporated overseas to lower their tax bills, but the move opened them up to unsolicited takeovers.", "pub_date": "2015-04-25T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "The Unintended Twist of Tax Inversions", "content_kicker": "Deal Professor", "kicker": "Deal Professor"}, "snippet": "Mylan and Perrigo reincorporated overseas to lower their tax bills, but the move opened them up to unsolicited takeovers.", "multimedia": [{"height": 126, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 601, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "601", "xlarge": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof-drug-articleLarge-v3.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/04/24/business/dbpix-dealprof-drug/dbpix-dealprof3-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/04/25/business/dealbook/the-unintended-twist-of-tax-inversions.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Taxation", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Federal Taxes (US)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Law and Legislation", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Perrigo Company", "name": "organizations"}], "blog": [], "_id": "553ab88638f0d8230f3b0fbe", "source": "The New York Times"}